U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07736404) titled 'A Study of SYH2082 Injection in Healthy Participants' on July 14.
Brief Summary: To evaluate the safety and tolerability of single dose of SYH2082 Injection in healthy participants.
Study Start Date: April 13
Study Type: INTERVENTIONAL
Condition:
Overweight or Obesity
Intervention:
DRUG: SYH2082 Injection
A subcutaneous injection in the abdomen of the corresponding dose of SYH2082 Injection according to the assigned dose cohort.
DRUG: Placebo
A subcutaneous injection in the abdomen of the corresponding dose of Placebo according to the assigned dose cohort.
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: CSPC Ouyi Pharm...